Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour
Cellular Oncology · 2024-02 · 47 (1) · 209-227
DOI: 10.1007/s13402-023-00863-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 22.08.2023. Verfasst von Hanzhao Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barncancerfonden, ARMEC Lindebergs foundation, Hjärnfonden.
Abstract (Originalsprache)
Purpose
Retinoblastoma, a childhood cancer, is most frequently caused by bi-allelic inactivation of RB1 gene. However, other oncogenic mutations such as MYCN amplification can induce retinoblastoma with proficient RB1 . Previously, we established RB1 -proficient MYCN -overexpressing retinoblastoma models both in human organoids and chicken. Here, we investigate the regulatory events in MYCN -induced retinoblastoma carcinogenesis based on the model in chicken.
Methods
MYCN transformed retinal cells in culture were obtained from in vivo MYCN electroporated chicken embryo retina. The expression profiles were analysed by RNA sequencing. Chemical treatments, qRT-PCR, flow cytometry, immunohisto- and immunocytochemistry and western blot were applied to study the properties and function of these cells.
Results
The expression profile of MYCN -transformed retinal cells in culture showed cone photoreceptor progenitor signature and robustly increased levels of E2Fs . This expression profile was consistently observed in long-term culture. Chemical treatments confirmed RB1 proficiency in these cells. The cells were insensitive to p53 activation but inhibition of E2f efficiently induced cell cycle arrest followed by apoptosis.
Conclusion
In conclusion, with proficient RB1 , MYCN -induced high level of E2F expression dysregulates the cell cycle and contributes to retinoblastoma carcinogenesis. The increased level of E2f renders the cells to adopt a similar mechanistic phenotype to a RB1 -deficient tumour.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
- Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Finn.Hallbook@igp.uu.se.
- Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 751 85, Uppsala, Sweden. Finn.Hallbook@igp.uu.se.
Förderung
- Barncancerfonden
- ARMEC Lindebergs foundation
- Hjärnfonden
- Stiftelsen Kronprinsessan Margaretas Arbetsnämnd för Synskadade
- Ögonfonden
- Uppsala University
Zitieren
APA
Zhang, H., Konjusha, D., Rafati, N., Tararuk, T., & Hallböök, F. (2024). Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour. Cellular Oncology, 47(1), 209-227. https://doi.org/10.1007/s13402-023-00863-0
Vancouver
Zhang H, Konjusha D, Rafati N, Tararuk T, Hallböök F. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour. Cellular Oncology. 2024;47(1):209-227. doi:10.1007/s13402-023-00863-0
BibTeX
@article{Zhang2024,
author = {Zhang, Hanzhao and Konjusha, Dardan and Rafati, Nima and Tararuk, Tatsiana and Hallböök, Finn},
title = {Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour},
journal = {Cellular Oncology},
year = {2024},
volume = {47},
number = {1},
pages = {209--227},
doi = {10.1007/s13402-023-00863-0}
}
EUVIMED